There are 3163 resources available
289P - Low risk febrile neutropenia: Does combined chemotherapy/immune checkpoint inhibitor necessitate a change in approach?
Presenter: Jamie Weaver
Session: Poster session 14
290P - Subtype-specific prognostic value of lobular histology in patients with early-stage breast cancer: A nationwide population-based study
Presenter: Guilherme Nader Marta
Session: Poster session 14
291P - Multi-center investigation of a detection model utilizing cfDNA for early-stage breast cancer screening
Presenter: Chao Ni
Session: Poster session 14
292P - Real-world evidence on risk of recurrence (ROR) in patients (pts) with node-negative (N0) and node-positive HR+/HER2– early breast cancer (EBC) from US electronic health records (EHR)
Presenter: Komal Jhaveri
Session: Poster session 14
293P - Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq
Presenter: Luc Cabel
Session: Poster session 14
294P - Survival outcomes according to tumor-infiltrating lymphocytes and 21-gene recurrence score in ER+HER2- breast cancer
Presenter: Sung Gwe Ahn
Session: Poster session 14
295P - Long-term clinical outcomes and treatment strategy considerations by ER expression level in breast cancer
Presenter: Yumi Wanifuchi-Endo
Session: Poster session 14
296P - Investigating survival by breast cancer molecular subtype in Australia: A population-based study
Presenter: Larissa Vaz-Goncalves
Session: Poster session 14
297P - Real-world data on prognostication of early stage breast cancer patients using CanAssist Breast- first immunohistochemistry based prognostic test developed and validated on Asians
Presenter: Vashista Maniar
Session: Poster session 14
Resources:
Abstract
298P - Enhancing prognostic accuracy for breast adenoid cystic carcinoma using machine learning models
Presenter: Sakhr Alshwayyat
Session: Poster session 14
Resources:
Abstract